Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

Published May 7, 2020

Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

The FDA's approval of Tabrecta marks a historic step in treatment for patients battling aggressive lung cancer. Researchers say this is just the beginning.

NOW
PLAYING
What Is the Role of Clinical Trials in Bladder Cancer?
NOW
PLAYING
New Research Underscores Importance of Genetic Testing in Non-Smokers' Lung Cancer Tumors
NOW
PLAYING
Remembering Actor Paul Newman Who Died From Lung Cancer 13 Years Ago
NOW
PLAYING
Immunotherapy Saved Lung Cancer Survivor Oswald Peterson
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.